MedTrace Logo

Qualitative and Quantitative Assessment of Marginal Bone Loss Following Flapless Guided Versus Conventional Implant Placement

NCT07663045 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-06-23

No results posted yet for this study

Summary

Marginal bone preservation is an important determinant of long-term implant success. Conventional flap implant placement provides direct visualization of the surgical site but may disturb the periosteal blood supply and contribute to early crestal bone remodeling.

Flapless guided implant placement is a minimally invasive approach that aims to preserve soft tissue architecture and vascular integrity. CBCT allows three-dimensional evaluation of peri implant bone levels, including mesial, distal, buccal, and lingual aspects.

Aim: The aim of this study was to compare flapless guided implant placement with conventional flap implant placement in terms of marginal bone loss, implant stability, postoperative pain, and soft-tissue healing.

Conditions

  • Guided Implant Placement
  • Delayed Implant
  • CBCT Segmentation

Interventions

PROCEDURE

Conventional Flap Implant Placement

manually raising the gingival tissue during dental implant surgery, this surgical procedure involves the placement of a dental implant directly into the alveolar or basal bone during a single session followed by the placement of a healing abutment without the use of surgical guides or advanced technology.

PROCEDURE

Flapless guided implant

a minimally invasive dental implant procedure where a surgical guide, often created using advanced imaging techniques like cone-beam computed tomography (CBCT) and computer-aided design (CAD), directs the precise placement of dental implants without the need for traditional flap elevation.

Sponsors & Collaborators

  • Gulf Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-07-01
Completion
2026-07-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663045 on ClinicalTrials.gov